Skip to main content

Table 1 Motility of C. elegans L4 larvae after exposure to G. senegalensis extracts

From: In vitro assessment of deworming potential of Guiera senegalensis in Nigerian ethnoveterinary industry using Caenorhabditis elegans

Treatment

Concentration (mg/ml)

C. elegans Bristol N2

C. elegans DA1316

% motility ± SE

24 h

48 h

24 h

48 h

Aqueous extract

0.2

85.2 ± 0.6a

72.2 ± 0.6a

88.8 ± 0.6a

73.2 ± 0.6a

0.4

82.9 ± 0.9a

69.2 ± 0.6b

84.2 ± 0.6b

69.5 ± 0.7b

0.6

78.9 ± 0.7b

64.2 ± 0.6c

80.2 ± 0.6c

63.2 ± 0.6c

0.8

72.9 ± 0.6c

57.2 ± 0.6d

76.6 ± 0.6d

58.8 ± 0.6d

1.0

67.6 ± 0.7d

47.2 ± 0.6e

68.9 ± 0.7e

52.5 ± 0.7e

2.0

58.9 ± 0.7e

16.6 ± 0.6f

63.9 ± 0.7f

18.6 ± 0.7f

Ivermectin (0.02 µg/ml)

38.6 ± 1.0f

2.3 ± 0.4g

98.5 ± 0.2g

95.7 ± 0.9g

Negative control

98.6 ± 0.7g

97.4 ± 0.7h

98.0 ± 0.5g

96.1 ± 0.4g

  

p < 0.001

p < 0.001

p < 0.001

p < 0.001

Methanol extract

0.2

77.9 ± 0.6a

63.2 ± 0.6a

80.2 ± 0.6a

67.5 ± 0.6a

0.4

74.3 ± 0.5a

60.3 ± 0.6a

78.5 ± 0.7a

62.2 ± 0.6b

0.6

69.6 ± 0.7b

56.3 ± 0.6b

74.2 ± 0.6a

59.5 ± 0.7b

0.8

65.9 ± 0.7c

52.3 ± 0.6c

72.9 ± 4.2a

55.3 ± 0.6c

1.0

57.3 ± 0.6d

35.9 ± 0.7d

61.2 ± 0.6b

39.3 ± 0.6d

2.0

51.8 ± 0.6e

7.2 ± 0.6e

54.2 ± 0.6b

8.3 ± 0.7e

Ivermectin (0.02 µg/ml)

36.5 ± 0.9f

2.7 ± 0.8f

98.0 ± 0.2c

96.7 ± 0.3f

Negative control

98.5 ± 0.7g

97.3 ± 0.4g

98.1 ± 0.7c

97.4 ± 0.7f

  

p < 0.001

p < 0.001

p < 0.001

p < 0.001

  1. Motility values with the same alphabet in the same column for the same extract treatments are not significantly different at p < 0.05 (Tukey’s HSD test)